IndustryTechCrunch·September 23, 2026
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Enveda just secured $311 million to advance nature-derived AI drugs into clinical trials. This funding will accelerate their research and development efforts in creating innovative treatments from natural compounds.
More in Industry
IndustryTechCrunch20h
At Meta Connect, the company’s smart glasses were everywhere
Article from TechCrunch about AI developments.
IndustryLatent Space22h
OpenRouter: from Seed to Stripe — with OpenRouter’s Alex Atallah & AMP’s Anjney Midha
Article from Latent Space about AI developments.
IndustryTechCrunch22h
Crusoe abandons $1.25B plan to use Boom turbines at AI data centers
Article from TechCrunch about AI developments.
IndustryTechCrunch23h
Unsecured OpenAI agents posted 53 user images on the internet without the lab’s knowledge
Article from TechCrunch about AI developments.